Buprenorphine vs Buprenorphine/Naloxone on the Effects of Maternal Symptomatology
Status:
Withdrawn
Trial end date:
2020-03-22
Target enrollment:
Participant gender:
Summary
This study will assesses the efficacy of buprenorphine/naloxone vs buprenorphine on maternal
withdrawal symptoms and drug cravings.
This is a randomized controlled trial to a cohort of pregnant women seeking
medication-assisted treatment for opioid use disorders. Half of participants will receive
buprenorphine, while the other half of participants receive a combination of
buprenorphine/naloxone
Phase:
Phase 4
Details
Lead Sponsor:
Stony Brook University
Treatments:
Buprenorphine Buprenorphine, Naloxone Drug Combination Naloxone